NYSE:TT - New York Stock Exchange, Inc. - IE00BK9ZQ967 - Common Stock - Currency: USD
TRANE TECHNOLOGIES PLC (NYSE:TT) shows strong growth, high profitability, and solid financial health, making it a potential pick for quality investors.
Trane Technologies (TT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Smart Beta ETF report for WWJD
(Bloomberg) -- Jack Bogle may have envisioned a world of rock-bottom fees and sleepy index funds — but the ETF market in 2025 looks more like a speculative arcade than a cost-cutting utopia.Most Read from BloombergUAE’s AI University Aims to Become Stanford of the GulfNY Wins Order Against US Funding Freeze in Congestion FightThe average fee of an exchange-traded fund launched this year has surged to a record 65 basis points, with leveraged trades, cryptocurrency, and active management among the
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Here is how Granite Construction (GVA) and Trane Technologies (TT) have performed compared to their sector so far this year.
Mentions: GVA
Trane Technologies (TT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Smart Beta ETF report for PKB
Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments Incorporated (TXN), The Boeing Company (BA) and NextEra Energy, Inc. (NEE).
We recently compiled a list of the 12 Most Promising EV Battery Stocks According to Wall Street Analysts. In this article, we are going to take a look at where EnerSys (NYSE:ENS) stands against the other EV Battery stocks. The term “EV battery stocks” describes businesses producing and developing electric vehicle batteries. This includes firms that provide […]
Overhauling your finances might be easier than you think. Financial woes can feel daunting, but a few quick changes could make a huge difference. Whether you're looking to find more room in your...
TT's first-quarter 2025 earnings and revenues increase year over year.
The headline numbers for Trane Technologies (TT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
On Tuesday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted earnings per share of $8.22, down 14% year-over-year, missing the consensus of $8.82. The company reported sales of $3.03 billion, down 4%, missing the consensus of $3.29 billion. In the first quarter, U.S. net sales for Eylea HD and Eylea decreased 26% year-over-year to $1.04 billion, including $307 million from Eylea HD. Also Read: FDA Sets The Countdown: Regeneron’s Eylea HD Could Be Headed For Major Expan